Investors purchased shares of CVS Health Corp (NYSE:CVS) on weakness during trading on Friday. $645.74 million flowed into the stock on the tick-up and $206.74 million flowed out of the stock on the tick-down, for a money net flow of $439.00 million into the stock. Of all stocks tracked, CVS Health had the 4th highest net in-flow for the day. CVS Health traded down ($0.28) for the day and closed at $55.60
CVS has been the subject of several analyst reports. UBS Group initiated coverage on shares of CVS Health in a report on Thursday, January 17th. They set a “buy” rating and a $75.00 price target for the company. Cantor Fitzgerald restated a “buy” rating and issued a $96.00 price objective on shares of CVS Health in a research report on Thursday, January 3rd. Bank of America restated a “buy” rating and issued a $92.00 price objective on shares of CVS Health in a research report on Thursday, January 3rd. SunTrust Banks lowered their price objective on shares of CVS Health to $85.00 and set a “buy” rating for the company in a research report on Thursday, February 21st. Finally, Morgan Stanley set a $92.00 price objective on shares of CVS Health and gave the company a “buy” rating in a research report on Friday, February 22nd. One analyst has rated the stock with a sell rating, three have assigned a hold rating and fifteen have assigned a buy rating to the stock. CVS Health presently has an average rating of “Buy” and an average price target of $84.18.
The company has a debt-to-equity ratio of 1.22, a quick ratio of 0.65 and a current ratio of 1.03. The stock has a market cap of $70.89 billion, a price-to-earnings ratio of 7.85, a PEG ratio of 1.06 and a beta of 0.95.
The firm also recently declared a quarterly dividend, which will be paid on Friday, May 3rd. Stockholders of record on Tuesday, April 23rd will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 3.60%. The ex-dividend date is Monday, April 22nd. CVS Health’s dividend payout ratio is 28.25%.
In other CVS Health news, Director C David Brown II purchased 10,000 shares of the stock in a transaction dated Monday, March 11th. The stock was bought at an average price of $53.18 per share, for a total transaction of $531,800.00. Following the transaction, the director now directly owns 16,222 shares in the company, valued at $862,685.96. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Larry J. Merlo sold 166,368 shares of CVS Health stock in a transaction that occurred on Tuesday, January 8th. The stock was sold at an average price of $69.04, for a total transaction of $11,486,046.72. Following the sale, the insider now owns 496,577 shares of the company’s stock, valued at approximately $34,283,676.08. The disclosure for this sale can be found here. In the last quarter, insiders have bought 23,600 shares of company stock valued at $1,270,896 and have sold 412,039 shares valued at $27,326,012. 0.53% of the stock is owned by insiders.
Several large investors have recently modified their holdings of the company. Levin Capital Strategies L.P. grew its holdings in CVS Health by 12,771.1% during the fourth quarter. Levin Capital Strategies L.P. now owns 972,409 shares of the pharmacy operator’s stock valued at $63,712,000 after purchasing an additional 964,854 shares during the period. Jackson Wealth Management LLC acquired a new position in CVS Health during the fourth quarter valued at approximately $1,535,000. Morgan Stanley grew its holdings in CVS Health by 7.9% during the third quarter. Morgan Stanley now owns 9,018,238 shares of the pharmacy operator’s stock valued at $709,914,000 after purchasing an additional 659,975 shares during the period. Capital International Investors grew its holdings in CVS Health by 5,579.8% during the third quarter. Capital International Investors now owns 9,161,488 shares of the pharmacy operator’s stock valued at $721,192,000 after purchasing an additional 9,000,188 shares during the period. Finally, Butensky & Cohen Financial Security Inc. grew its holdings in CVS Health by 1.5% during the fourth quarter. Butensky & Cohen Financial Security Inc. now owns 27,715 shares of the pharmacy operator’s stock valued at $1,816,000 after purchasing an additional 409 shares during the period. Institutional investors own 84.55% of the company’s stock.
ILLEGAL ACTIVITY WARNING: “Traders Buy CVS Health (CVS) on Weakness” was first posted by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of United States and international trademark and copyright law. The correct version of this piece of content can be read at https://www.chaffeybreeze.com/2019/03/15/traders-buy-cvs-health-cvs-on-weakness.html.
About CVS Health (NYSE:CVS)
CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. It operates through Pharmacy Services and Retail/LTC segments. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.